Roche Diagnostics Licenses the Technology used for the LightCycler<sup>®</sup> System to BIOTECON
29 Apr 2008Roche Diagnostics and BIOTECON Diagnostics GmbH, Potsdam, Germany, have entered into a licensing agreement concerning Roche’s LightCycler system technology. Under the terms of the agreement, Roche grants a non-exclusive worldwide license to BIOTECON authorizing them to develop, produce, and sell kits in the food and GMO (Genetically Modified Organisms) analysis field that are designed for use on the Roche LightCycler Instrument. The agreement includes the use of Roche’s melting curve analysis technology. Financial terms of the agreement were not disclosed.
As an international biotechnology company BIOTECON Diagnostics develops, produces, and markets its innovative complete rapid PCR-based kits for the detection of pathogenic contamination in food, for spoilage microorganisms, and for genetically modified organisms. The company offers solutions for the food and beverage industry as well as for producers of pharmaceuticals and cosmetics.
With the licensing of the LightCycler instrument technology, BIOTECON will enhance the technological development and broaden the spectrum of applications especially in the fields of food and cosmetics," states Dr. Manfred Baier, Head of Roche Applied Science, a business area of Roche Diagnostics.
“The LightCycler System Technology License represents a significant milestone for our company”, states Kornelia Berghof-Jäger, CEO of BIOTECON Diagnostics. It enables us to strengthen our position in the field of molecular food diagnostics and, together with the food industry, provide even greater food safety."